Calidi Biotherapeutics, Inc.
https://calidibio.com/
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Latest From Calidi Biotherapeutics, Inc.
Finance Watch: Two Biopharma IPOs Bring US Total To 17
Public Company Edition: Neumora grossed $250m and RayzeBio raised $311m in the first initial public offerings since early August. Also, ImmunityBio completes $470m in equity and debt financings, Bausch + Lomb sells $1.4bn worth of notes and Arbutus is among firms making cuts to conserve cash.
Tech Transfer Roundup: Mydecine, Johns Hopkins Pair Up To Study Psychedelics
BioMed X teams with J&J on inflammation, drug delivery research. Stem cell firm Calidi inks licensing deals with U. of Chicago, City of Hope and Northwestern. MD Anderson teams with Blueprint and Hummingbird.
Herbalife Payments, Folic Acid Recommendation: Health & Wellness Industry News Roundup
Herbalife checks in the mail from FTC; PSTF recommends daily folic acid supplementation; OmniActive acquires ingredient firm Indfrag; and Vancouver firm prepares to launch 40J's products
Start-Up Execs On The Move, November 2015
Recent executive-level hires and director appointments at venture capital firms and biopharma and medtech start-ups.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
- Drug Delivery
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice